Home » Topics » Briefs » Other news to note

Other news to note
RSS

Ajinomoto Pharmaceuticals and Yoshindo to form joint venture

Dec. 28, 2012

Covidien to acquire CV Ingenuity

Dec. 28, 2012

Infinity Pharmaceuticals amends license agreement with Millennium

Dec. 28, 2012

Forest and Glenmark to develop agents for chronic inflammatory conditions

Dec. 28, 2012

Acorda Therapeutics completes acquisition of Neuronex

Dec. 27, 2012

Lundbeck to divest non-core products to Recordati

Dec. 18, 2012

Vivalis and Intercell agree to merge

Dec. 18, 2012

Gilead Sciences signs definitive agreement to acquire YM BioSciences

Dec. 17, 2012

Amgen set to acquire deCODE Genetics

Dec. 14, 2012

BrainStorm Cell Therapeutics receives grant from Israel's Office of the Chief Scientist

Dec. 14, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.